The World Health Organisation (WHO) says the listing of 14 herbal medicinal products by NAFDAC against COVID-19 and the ongoing clinical trials on them, is in line with the Regional Expert Committee on COVID-19 aim of elevating the standards of clinical trials of traditional medicine for COVID-19.
WHO’s Country Representative Dr. Walter Mulombo stated this on Monday in commemoration of the 2021 Traditional Medicine Day in Abuja.
Represented by the EPI Focal Point, Universal Health Coverage(UHC) Dr. Kofi Boateng, he said the ongoing research in the National Institute for Pharmaceutical Research & Development (NIPRD) and other higher institutions, highlights the interest of Nigeria to develop and promote African Traditional Medicines.
He said Africa has a long history of traditional medicine and practitioners that play an important role in providing care to populations over the centuries.
Dr Mulombo added that WHO recognizes that traditional, complementary and alternative medicine has many benefits when properly harnessed noting that researches into traditional medicines is an effort in the right direction
He said the WHO will continue to provide technical assistance to the TCAM department, NIPRD and NAFDAC in improving the quality of medicinal products and ensure the listing of these products in the National Essential Medicines List.
He added that WHO remains committed to supporting the Government of Nigeria in its goal of achieving self-sufficiency in the local production of pharmaceuticals (including Vaccines), traditional medicine and researches.
The theme of this year’s Traditional Medicine Day is “The Potential Contribution of Traditional Medicine to COVID-19 Response”